ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,229Medicare Part D Prescriptions Filled, Including Refills

Rank: 125 out of 336

$611K Total Retail Price of All Prescriptions

Rank: 113 out of 336

331 Patients Receiving at Least One Drug in Part D
66%Patients 65 Years and Older
58% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

24% of this provider’s 331 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

3% of this provider’s 7,478 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
OMEPRAZOLE 454 250 1 3
AMLODIPINE BESYLATE 406 290 2 1
CARVEDILOL 389 319 3 13
FUROSEMIDE 307 247 4 4
SIMVASTATIN 284 211 5 5
PRAVASTATIN SODIUM 276 182 6 10
GABAPENTIN 270 131 7 11
HYDROCODONE-ACETAMINOPHEN 261 149 S3 8 2
TRAMADOL HCL 252 133 9 20
POTASSIUM CHLORIDE 251 196 10 9
LEVOTHYROXINE SODIUM 245 205 11 7
ATORVASTATIN CALCIUM 244 178 12 14
LISINOPRIL 241 175 13 6
METFORMIN HCL 181 122 14 8
NEXIUM 168 123 15 24
FENOFIBRATE 140 101 16 72
ALENDRONATE SODIUM 138 109 17 54
NAMENDA 128 128 18 39
FLUTICASONE PROPIONATE 122 78 19 49
WARFARIN SODIUM 117 83 20 17
METOPROLOL SUCCINATE 108 87 21 15
JANUVIA 107 81 22 67
DILTIAZEM 24HR CD 106 59 23 126
PROPRANOLOL HCL 97 40 24 101
CYCLOBENZAPRINE HCL 97 66 R 24 65
ALLOPURINOL 96 63 26 30
HYDROCHLOROTHIAZIDE 95 38 27 12
LISINOPRIL-HYDROCHLOROTHIAZIDE 89 57 28 23
TIZANIDINE HCL 89 43 28 83
RANITIDINE HCL 85 39 30 36
METHYLPREDNISOLONE 85 61 30 104
CITALOPRAM HBR 81 59 32 21
FLUOXETINE HCL 80 16 33 81
BYSTOLIC 78 69 34 79
ZOLPIDEM TARTRATE 77 42 35 18
LANTUS 77 64 35 56
GLIPIZIDE ER 76 52 37 91
DONEPEZIL HCL 76 68 37 27
TRAZODONE HCL 75 41 39 46
PAROXETINE HCL 71 48 40 64
PREDNISONE 71 46 40 48
AZITHROMYCIN 70 55 42 58
MELOXICAM 68 39 43 19
ZETIA 66 41 44 74
KLOR-CON M20 66 27 44 51
METOPROLOL TARTRATE 64 35 46 16
GLYBURIDE 62 38 R 47 76
CRESTOR 61 39 48 25
INDOMETHACIN 61 11 R 48 233
LYRICA 61 42 48 70
AGGRENOX 60 55 51 133
POLYETHYLENE GLYCOL 3350 59 59 52 68
BUSPIRONE HCL 56 39 53 113
CYMBALTA 56 25 53 52
SERTRALINE HCL 55 53 55 33
NORTRIPTYLINE HCL 55 30 55 372
LOSARTAN POTASSIUM 54 42 57 22
MONTELUKAST SODIUM 54 27 57 140
LANTUS SOLOSTAR 54 21 57 124
SINGULAIR 54 21 57 85
PANTOPRAZOLE SODIUM 53 24 61 40
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 18, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.